Page last updated: 2024-11-03

proadifen and EHS Tumor

proadifen has been researched along with EHS Tumor in 2 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Research Excerpts

ExcerptRelevanceReference
"Phenobarbital pretreatment reduced both the antitumor efficacy and toxicity of CCNU (factor of approximately 0."1.27Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine. ( Siemann, DW, 1983)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wiebkin, P1
Sieg, MS1
Nelson, RE1
Hines, RN1
Prough, RA1
Siemann, DW1

Other Studies

2 other studies available for proadifen and EHS Tumor

ArticleYear
Inhibition of metabolism-mediated cytotoxicity by 1,1-disubstituted hydrazines in mouse mastocytoma (line P815) cells.
    Biochemical pharmacology, 1982, Sep-15, Volume: 31, Issue:18

    Topics: Animals; Biotransformation; Cell Survival; Cells, Cultured; Coumarins; Cyclophosphamide; Hydrazines;

1982
Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
    Cancer treatment reports, 1983, Volume: 67, Issue:3

    Topics: Animals; Female; Lomustine; Mice; Mice, Inbred C3H; Nitrosourea Compounds; Phenobarbital; Proadifen;

1983